Authorizes prescription of Schedule II controlled dangerous substances through telemedicine or telehealth without certain in-person requirements.
2026/05/07 Introduced, Referred to Assembly Health Committee
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | NJ A5534 | 0 | 16.19 | 24-09-2026 |
| 2 | NJ A4694 | 0 | 13.7 | 16-03-2026 |
| 3 | NJ A4867 | 0 | 15.26 | 04-05-2026 |
| 4 | NJ A4572 | 0 | 17.14 | 10-03-2026 |
| 5 | NJ A5068 | 0 | 10.85 | 14-05-2026 |
| 6 | NJ A4930 | 0 | 16.67 | 07-05-2026 |
| 7 | NJ A4181 | 0 | 13.78 | 19-02-2026 |
| 8 | NJ A5231 | 0 | 13.78 | 08-06-2026 |
| 9 | NJ A5047 | 0 | 14.93 | 11-05-2026 |
| 10 | NJ A4980 | 0 | 17.41 | 07-05-2026 |